247 related articles for article (PubMed ID: 25978361)
21. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
[TBL] [Abstract][Full Text] [Related]
22. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
23. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
25. Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.
Molina-Berríos A; Campos-Estrada C; Henriquez N; Faúndez M; Torres G; Castillo C; Escanilla S; Kemmerling U; Morello A; López-Muñoz RA; Maya JD
PLoS Negl Trop Dis; 2013; 7(4):e2173. PubMed ID: 23638194
[TBL] [Abstract][Full Text] [Related]
26. Immunological exhaustion and functional profile of CD8
Pérez-Antón E; Egui A; Thomas MC; Simón M; Segovia M; López MC
Acta Trop; 2020 Feb; 202():105242. PubMed ID: 31669531
[TBL] [Abstract][Full Text] [Related]
27.
Rial MS; Seremeta KP; Esteva MI; Búa J; Salomon CJ; Fichera LE
Parasitology; 2021 Apr; 148(5):566-575. PubMed ID: 33298212
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells.
Jiang JL; Wang S; Li NS; Zhang XH; Deng HW; Li YJ
Biochem Cell Biol; 2007 Feb; 85(1):66-77. PubMed ID: 17464346
[TBL] [Abstract][Full Text] [Related]
29. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
López-Muñoz R; Faúndez M; Klein S; Escanilla S; Torres G; Lee-Liu D; Ferreira J; Kemmerling U; Orellana M; Morello A; Ferreira A; Maya JD
Exp Parasitol; 2010 Feb; 124(2):167-71. PubMed ID: 19735656
[TBL] [Abstract][Full Text] [Related]
30. 15-epi-lipoxin A
Chen Y; Zheng Y; Xin L; Zhong S; Liu A; Lai W; Liu L; Lin C; Liao C; Zeng J; Zhang L
Biomed Pharmacother; 2019 Sep; 117():109099. PubMed ID: 31200255
[TBL] [Abstract][Full Text] [Related]
31. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
32. Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.
Caldas IS; da Matta Guedes PM; dos Santos FM; de Figueiredo Diniz L; Martins TA; da Silva do Nascimento AF; Azevedo MA; de Lima WG; Neto RM; Torres RM; Talvani A; Bahia MT
Trop Med Int Health; 2013 Jan; 18(1):75-84. PubMed ID: 23107306
[TBL] [Abstract][Full Text] [Related]
33. Lack of modulatory effect of simvastatin on indoxyl sulfate-induced activation of cultured endothelial cells.
Lee CT; Lee YT; Ng HY; Chiou TT; Cheng CI; Kuo CC; Wu CH; Chi PJ; Lee WC
Life Sci; 2012 Jan; 90(1-2):47-53. PubMed ID: 22056374
[TBL] [Abstract][Full Text] [Related]
34. The ubiquinone synthesis pathway is a promising drug target for Chagas disease.
Nara T; Nakagawa Y; Tsuganezawa K; Yuki H; Sekimata K; Koyama H; Ogawa N; Honma T; Shirouzu M; Fukami T; Matsuo Y; Inaoka DK; Kita K; Tanaka A
PLoS One; 2021; 16(2):e0243855. PubMed ID: 33539347
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
36. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
[TBL] [Abstract][Full Text] [Related]
37. Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.
Vinuesa T; Herráez R; Oliver L; Elizondo E; Acarregui A; Esquisabel A; Pedraz JL; Ventosa N; Veciana J; Viñas M
Am J Trop Med Hyg; 2017 Nov; 97(5):1469-1476. PubMed ID: 29016287
[TBL] [Abstract][Full Text] [Related]
38. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.
Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA
Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190
[TBL] [Abstract][Full Text] [Related]
39. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
40. Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease.
Laucella SA; Segura EL; Riarte A; Sosa ES
Clin Exp Immunol; 1999 Dec; 118(3):423-7. PubMed ID: 10594562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
